{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01021",
      "entity_text" : "AFVI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00784",
      "entity_text" : "DOAC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Organ" : [ "uberon:UBERON:0006611" ]
    }
  },
  "verbose_text" : "The duration of the DOAC therapy and the persistence of bleeding despite DOAC suspension (10 days before hospitalization) are robust evidence to exclude interaction between DOAC and AFVI.",
  "reading_complete" : "2020-08-02T11:13:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:12:36Z",
  "trigger" : "interaction",
  "evidence" : [ "interaction between DOAC and AFVI" ],
  "pmc_id" : "7170712",
  "score" : 0
}